GGrantIndex
← Leaderboards

Hanno Steen

Boston Children'S Hospital

$18,284,696
Attributed
$22,539,038
Total exposure
14
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4M · FY200625
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$22,539,038 · 14

By mechanism

U19$6,950,868 · 6
U24$6,325,636 · 1
R01$5,763,127 · 3
U01$2,361,983 · 1
S10$599,998 · 1
R21$486,750 · 1

Most similar at Boston Children'S Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Proteomics

Research focus

ProteomicsProteinsBiological MarkersProteomeSamplingCohortBloodPlasmaParticipantInsightResponseBaseMolecularLiquid Chromatography Mass SpectrometryValidationFundingMapsAdultPhenotypeInterestResolutionInfectionBiomarker IdentificationNewborn Infant

Grant awards (37)

Protein biomarkers to predict pain outcomes after total pancreatectomy with islet autotransplant$735,823
R01 · FY2025 · DK
Biomarkers to stratify pain severity and type in pancreatic disease$716,188
R01 · FY2025 · DK · contact PI
Proteomics and Metabolomics Core: IDEAL shapes vaccine response, susceptibility to respiratory infectious disease and asthma$191,753
U19 · FY2025 · AI · contact PI
High-throughput proteomics using submicroliter amounts of plasma for comprehensive assessment of the immune status$1,178,245
U24 · FY2024 · AI · contact PI
Protein biomarkers to predict pain outcomes after total pancreatectomy with islet autotransplant$706,314
R01 · FY2024 · DK
Biomarkers to stratify pain severity and type in pancreatic disease$687,602
R01 · FY2024 · DK · contact PI
Proteomics and Metabolomics Core: IDEAL shapes vaccine response, susceptibility to respiratory infectious disease and asthma$264,457
U19 · FY2024 · AI · contact PI
High-throughput proteomics using submicroliter amounts of plasma for comprehensive assessment of the immune status$1,178,245
U24 · FY2023 · AI · contact PI
Biomarkers to stratify pain severity and type in pancreatic disease$778,070
R01 · FY2023 · DK · contact PI
Protein biomarkers to predict pain outcomes after total pancreatectomy with islet autotransplant$774,125
R01 · FY2023 · DK
Dried blood spot proteomics analysis of newborn screening cards to identify prognostic markers of SIDS risk$486,750
R21 · FY2023 · HD
Proteomics and Metabolomics Core: IDEAL shapes vaccine response, susceptibility to respiratory infectious disease and asthma$282,238
U19 · FY2023 · AI · contact PI
High-throughput proteomics using submicroliter amounts of plasma for comprehensive assessment of the immune status$1,178,245
U24 · FY2022 · AI · contact PI
Proteomics and Metabolomics Core: IDEAL shapes vaccine response, susceptibility to respiratory infectious disease and asthma$265,987
U19 · FY2022 · AI · contact PI
Proteomics Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity$2,275,700
U19 · FY2021 · AI · contact PI
High-throughput proteomics using submicroliter amounts of plasma for comprehensive assessment of the immune status$1,178,244
U24 · FY2021 · AI · contact PI
High-throughput proteomics using submicroliter amounts of plasma for comprehensive assessment of the immune status$434,412
U24 · FY2021 · AI · contact PI
Proteomics Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity$116,395
U19 · FY2021 · AI · contact PI
Proteomics Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity$2,174,014
U19 · FY2020 · AI · contact PI
High-throughput proteomics using submicroliter amounts of plasma for comprehensive assessment of the immune status$1,178,245
U24 · FY2020 · AI · contact PI
Proteomics Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity$111,329
U19 · FY2020 · AI · contact PI
Proteomics Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity$111,094
U19 · FY2020 · AI · contact PI
The Ohio State University Pancreatic Disorders Network (OSU-PDN)$428,715
U01 · FY2019 · DK
Proteomics Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity$162,752
U19 · FY2019 · AI · contact PI
The Ohio State University Pancreatic Disorders Network (OSU-PDN)$53,541
U01 · FY2019 · DK
Proteomics Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity$835,849
U19 · FY2018 · AI · contact PI
The Ohio State University Pancreatic Disorders Network (OSU-PDN)$439,313
U01 · FY2018 · DK
The Ohio State University Pancreatic Disorders Network (OSU-PDN)$442,874
U01 · FY2017 · DK
Proteomics Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity$159,300
U19 · FY2017 · AI · contact PI
The Ohio State University Pancreatic Disorders Network (OSU-PDN)$503,511
U01 · FY2016 · DK
The Ohio State University Pancreatic Disorders Network (OSU-PDN)$494,029
U01 · FY2015 · DK
Defining the true nature of the minimal cell cycle with quantitative proteomics$332,462
R01 · FY2013 · GM · contact PI
TripleTOF 5600 Hybrid Mass Spectrometer$599,998
S10 · FY2012 · OD · contact PI
Defining the true nature of the minimal cell cycle with quantitative proteomics$344,520
R01 · FY2012 · GM · contact PI
Defining the true nature of the minimal cell cycle with quantitative proteomics$344,189
R01 · FY2011 · GM · contact PI
Defining the true nature of the minimal cell cycle with quantitative proteomics$343,834
R01 · FY2010 · GM · contact PI
PROTEOMICS CORE$50,676
P30 · FY2006 · DK · contact PI